HNF4A and neoplasm: As shown in Figure 3F, the siRNA-mediated knock-down of β-catenin reduced the sensitivity of cells to 4βHWE, further confirming that β-catenin/TCF is required for the anti-tumor activity of 4βHWE, in part at least.